Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [18]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15911-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15911-1-AP, RRID:AB_2131434
- Product name
- KIF20A antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated KIF20A antibody (Cat. #15911-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references KIF20A promotes cervical cancer progression by interacting with CLIP1.
Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study.
DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A.
The mechanisms of MTOCs maturation in human and mouse oocytes.
Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification.
Targeting kinesin family member 20A sensitizes stem-like triple-negative breast cancer cells to standard chemotherapy.
NudCL2 is required for cytokinesis by stabilizing RCC2 with Hsp90 at the midbody.
Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer.
Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination.
Comprehensive analysis of transcriptome-wide N6-methyladenosine methylomes in the Barrett's esophagus in rats.
Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
Mir-153-3p Modulates the Breast Cancer Cells' Chemosensitivity to Doxorubicin by Targeting KIF20A.
The mechanism of acentrosomal spindle assembly in human oocytes.
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Bisphenol A triggers the malignancy of acute myeloid leukemia cells via regulation of IL-4 and IL-6.
Coupling fission and exit of RAB6 vesicles at Golgi hotspots through kinesin-myosin interactions.
Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Ma X, Xu Z, Chen Y, Jiang F, Jiao Y, Wang W, Wang E
Scientific reports 2026 Mar 3;16(1)
Scientific reports 2026 Mar 3;16(1)
Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study.
Li L, Pang J, Chen J, Pan Y, Liang L, Bai X, He Y, Yang H
Medicine 2026 Jan 23;105(4):e47262
Medicine 2026 Jan 23;105(4):e47262
DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A.
Yu M, Zhao H, Sun Y
Frontiers in endocrinology 2025;16:1591390
Frontiers in endocrinology 2025;16:1591390
The mechanisms of MTOCs maturation in human and mouse oocytes.
Gu H, Wu L, Yin M, Du X, Fu J, Xu F, Ye Z, Zhang X, Jing H, Luo Y, Li W, Sun X, He L, Kuang Y, Lyu Q, Wu T, Wang L, Sang Q
Science bulletin 2025 Oct 15;70(19):3202-3214
Science bulletin 2025 Oct 15;70(19):3202-3214
Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification.
Huan Y, She P, Cai X, Qi J, Zhang C
Journal of the Egyptian National Cancer Institute 2025 Feb 24;37(1):5
Journal of the Egyptian National Cancer Institute 2025 Feb 24;37(1):5
Targeting kinesin family member 20A sensitizes stem-like triple-negative breast cancer cells to standard chemotherapy.
Adachi Y, Chen W, Zhang C, Wang T, Gildor N, Shi R, Fu H, Takeda M, Liang Q, Zhao F, Liu H, Fang J, Zhou J, Yao H, Hu L, Li S, Guo L, Xu L, Xie L, Chen X, Liao C, Zhang Q
The Journal of clinical investigation 2025 Dec 15;135(24)
The Journal of clinical investigation 2025 Dec 15;135(24)
NudCL2 is required for cytokinesis by stabilizing RCC2 with Hsp90 at the midbody.
Xu X, Huang Y, Yang F, Sun X, Lin R, Feng J, Yang M, Shao J, Liu X, Zhou T, Xie S, Yang Y
Protein & cell 2024 Oct 1;15(10):766-782
Protein & cell 2024 Oct 1;15(10):766-782
Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer.
Zhang R, Li L, Li H, Bai H, Suo Y, Cui J, Wang Y
Journal of ginseng research 2024 Jan;48(1):40-51
Journal of ginseng research 2024 Jan;48(1):40-51
Inhibition of KIF20A enhances the immunotherapeutic effect of hepatocellular carcinoma by enhancing c-Myc ubiquitination.
Chen S, Zhao L, Liu J, Han P, Jiang W, Liu Y, Hou J, Wang F, Li J
Cancer letters 2024 Aug 28;598:217105
Cancer letters 2024 Aug 28;598:217105
Comprehensive analysis of transcriptome-wide N6-methyladenosine methylomes in the Barrett's esophagus in rats.
Zou K, Dong H, Li M, Zhang Y, Zhang K, Song D, Chu C
Genomics 2023 Sep;115(5):110687
Genomics 2023 Sep;115(5):110687
Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
Wang Y, Tian X, Zhu SX, Xu WH, Anwaier A, Su JQ, Gan HL, Qu YY, Zhao JY, Zhang HL, Ye DW
World journal of surgical oncology 2023 Mar 16;21(1):98
World journal of surgical oncology 2023 Mar 16;21(1):98
Mir-153-3p Modulates the Breast Cancer Cells' Chemosensitivity to Doxorubicin by Targeting KIF20A.
Rahman KU, Yang S, Azam N, Yuan Z, Yu J, Zhao C, Feng B
Cancers 2023 Mar 11;15(6)
Cancers 2023 Mar 11;15(6)
The mechanism of acentrosomal spindle assembly in human oocytes.
Wu T, Dong J, Fu J, Kuang Y, Chen B, Gu H, Luo Y, Gu R, Zhang M, Li W, Dong X, Sun X, Sang Q, Wang L
Science (New York, N.Y.) 2022 Nov 18;378(6621):eabq7361
Science (New York, N.Y.) 2022 Nov 18;378(6621):eabq7361
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma.
Zhang L, Li Y, Wang X, Ping Y, Wang D, Cao Y, Dai Y, Liu W, Tao Z
Journal of Cancer 2021;12(12):3626-3647
Journal of Cancer 2021;12(12):3626-3647
KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Zhang Q, Di J, Ji Z, Mi A, Li Q, Du X, Wang A, Wang A, Qin C
Disease markers 2020;2020:2032679
Disease markers 2020;2020:2032679
Bisphenol A triggers the malignancy of acute myeloid leukemia cells via regulation of IL-4 and IL-6.
Zhang S, Li J, Fan J, Wu X
Journal of biochemical and molecular toxicology 2020 Jan;34(1):e22412
Journal of biochemical and molecular toxicology 2020 Jan;34(1):e22412
Coupling fission and exit of RAB6 vesicles at Golgi hotspots through kinesin-myosin interactions.
Miserey-Lenkei S, Bousquet H, Pylypenko O, Bardin S, Dimitrov A, Bressanelli G, Bonifay R, Fraisier V, Guillou C, Bougeret C, Houdusse A, Echard A, Goud B
Nature communications 2017 Nov 1;8(1):1254
Nature communications 2017 Nov 1;8(1):1254
Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X, He QY
Proteomics 2012 Aug;12(14):2391-9
Proteomics 2012 Aug;12(14):2391-9
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The KIF20A antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human KIF20A. This antibody recognizes human, mouse, rat antigen. The KIF20A antibody has been validated for the following applications: ELISA, WB analysis.
